Ajay Tambralli - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ajay Tambralli

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Blood Advances|July 24, 2025

A Disrupted Adenosinergic Axis Facilitates Platelet Activation in APS: Exploring a Novel Therapeutic TargetSomanathapura K NaveenKumar, Thalia G Newman, Bruna Mazetto Fonseca, et al.

The Journal of Clinical Investigation|June 13, 2024

Neutrophil glucose flux as a therapeutic target in antiphospholipid syndromeAjay Tambralli, Alyssa Harbaugh, Somanathapura K NaveenKumar, et al.

Circulation|August 29, 2025

Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated SignalingHui Shi, Wenying Liang, Zhixia Yang, et al.

JCI Insight|April 1, 2025

Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Blood Advances|July 24, 2025

A Disrupted Adenosinergic Axis Facilitates Platelet Activation in APS: Exploring a Novel Therapeutic TargetSomanathapura K NaveenKumar, Thalia G Newman, Bruna Mazetto Fonseca, et al.

The Journal of Clinical Investigation|June 13, 2024

Neutrophil glucose flux as a therapeutic target in antiphospholipid syndromeAjay Tambralli, Alyssa Harbaugh, Somanathapura K NaveenKumar, et al.

Circulation|August 29, 2025

Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated SignalingHui Shi, Wenying Liang, Zhixia Yang, et al.

JCI Insight|April 1, 2025

Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.

Pageof 3